Financials data is unavailable for this security.
View more
Year on year Dexcom Inc grew revenues 15.60% from 4.03bn to 4.66bn while net income improved 45.14% from 576.20m to 836.30m.
| Gross margin | 62.09% |
|---|---|
| Net profit margin | 17.94% |
| Operating margin | 19.56% |
| Return on assets | 13.04% |
|---|---|
| Return on equity | 34.50% |
| Return on investment | 21.58% |
More ▼
Cash flow in USDView more
In 2025, Dexcom Inc increased its cash reserves by 51.34%, or 311.80m. The company earned 1.44bn from its operations for a Cash Flow Margin of 30.90%. In addition the company generated 536.00m cash from investing, though they paid out 1.69bn more in financing than they received.
| Cash flow per share | 2.68 |
|---|---|
| Price/Cash flow per share | 24.91 |
| Book value per share | 7.14 |
|---|---|
| Tangible book value per share | 6.89 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.88 |
|---|---|
| Quick ratio | 1.59 |
| Total debt/total equity | 0.4715 |
|---|---|
| Total debt/total capital | 0.3204 |
More ▼
Growth rates in USD
SmartText is unavailable
| EPS growth(5 years) | 9.54 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 47.90 |
